REFERENCES
- Akiyama T., Ishida J., Nakagawa S., Ogawara H., Watanabe S., Itoh N., Shibuya M., Fukami Y. Genistein, a specific inhibitor of tyrosine-specific protein kinases. The Journal of Biological Chemistry 1987; 262: 5592–5595, [INFOTRIEVE], [CSA]
- Ambra R., Rimbach G., de Pascual Teresa S., Fuchs D., Wenzel U., Daniel H., Virgili F. Genistein affects the expression of genes involved in blood pressure regulation and angiogenesis in primary human endothelial cells. Nutrition, Metabolism & Cardiovascular Diseases 2006; 16: 35–43, [CROSSREF], [CSA]
- Bach T. L., Barsigian C., Chalupowicz D. G., Busler D., Yaen C. H., Grant D. S., Martinez J. VE-cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Experimental Cell Research 1998; 238: 324–334, [INFOTRIEVE], [CROSSREF], [CSA]
- Chen X. L., Dodd G., Thomas S., Zhang X., Wasserman M. A., Rovin B. H., Kunsch C. Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. American Journal of Physiology-Heart and Circulatory Physiology 2006; 290: H1862–H1870, [INFOTRIEVE], [CROSSREF], [CSA]
- Dejana E., Bazzoni G., Lampugnani M. G. Vascular endothelial (VE)-cadherin: only an intercellular glue?. Experimental Cell Research 1999; 252: 13–19, [INFOTRIEVE], [CROSSREF], [CSA]
- Dye J. F., Lawrence L., Linge C., Leach L., Firth J. A., Clark P. Distinct patterns of microvascular endothelial cell morphology are determined by extracellular matrix composition. Endothelium 2004; 11: 151–167, [INFOTRIEVE], [CROSSREF], [CSA]
- Errede M., Benagiano V., Girolamo F., Flace P., Bertossi M., Roncali L., Virgintino D. Differential expression of connexin43 in fetal, adult and tumour-associated human brain endothelial cells. Histochemical Journal 2002; 34: 265–271, [INFOTRIEVE], [CROSSREF], [CSA]
- Fang F., Orend G., Watanabe N., Hunter T., Ruoslahti E. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 1996; 271: 499–502, [INFOTRIEVE], [CSA]
- Fotsis T., Pepper M., Adlercreutz H., Fleischmann G., Hase T., Montesano R., Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 1993; 90: 2690–2694, [INFOTRIEVE], [CROSSREF], [CSA]
- Fukai F., Mashimo M., Akiyama K., Goto T., Tanuma S., Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Experimental Cell Research 1998; 242: 92–99, [INFOTRIEVE], [CROSSREF], [CSA]
- Glienke J., Sturz A., Menrad A., Thierauch K.-H. CRIM1 is involved in endothelial cell capillary formation in vitro and is expressed in blood vessels in vivo. Mechanisms of Development 2002; 119: 165–175, [INFOTRIEVE], [CROSSREF], [CSA]
- Gonzalez-Amaro R., Sanchez-Madrid F. Cell adhesion molecules: selectins and integrins. Critical Reviews in Immunology 1999; 19: 389–429, [INFOTRIEVE], [CSA]
- Jacobsen B. K., Knutsen S. F., Fraser G. E. Does high soy milk intake reduce prostate cancer incidence? The Adventist health study (United States). Cancer Causes and Control 1998; 9: 553–557, [INFOTRIEVE], [CROSSREF], [CSA]
- Kim M. H. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases. Journal of Cellular Biochemistry 2003; 89: 529–538, [INFOTRIEVE], [CROSSREF], [CSA]
- Kiriakidis S., Hogemeier O., Starcke S., Dombrowski F., Hahne J. C., Pepper M., Jha H. C., Wernert N. Novel tempeh (fermented soybean) isoflavones inhibit in vivo angiogenesis in the chicken chorioallantoic membrane assay. British Journal of Nutrition 2005; 93: 317–323, [INFOTRIEVE], [CROSSREF], [CSA]
- Lampugnani M. G., Resnati M., Raiteri M., Ppigott R., Marchisio P. C., Pisacane A., et al. A novel endothelial specific membrane protein is a marker of cell-cell contacts. Journal of Cell Biology 1992; 118: 1511–1152, [INFOTRIEVE], [CROSSREF], [CSA]
- Li Y., Sarkar F. H. Down-regualation of invasion and angiogenesis-ralated genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein. Cancer Letter 2002; 186: 157–164, [CROSSREF], [CSA]
- Madhusudan S., Harris A. L. Drug inhibition of angiogenesis. Current Opinion of Pharmacology 2002; 2: 403–414, [CROSSREF], [CSA]
- May M. J., Wheeler-Jones C. P., Pearson J. D. Effects of protein tyrosine kinase inhibitors on cytokine-induced adhesion molecule expression by human umbilical vein endothelial cells. British Journal of Pharmacology 1996; 118: 1761–1771, [INFOTRIEVE], [CSA]
- Meikrantz W., Schlegel R. Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases. Journal of Biological Chemistry 1996; 271: 10205–10209, [INFOTRIEVE], [CROSSREF], [CSA]
- Pepper M. S., Hazel S. J., Humpel M., Schleuning W. D. 8-Prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. Journal of Cellular Physiology 2004; 199: 98–107, [INFOTRIEVE], [CROSSREF], [CSA]
- Pepper M. S., Meda P. Basic fibroblast growth factor increases junctional communication and connexin43 expression in microvascular endothelial cells. Journal of Cellular Physiology 1992; 153: 196–205, [INFOTRIEVE], [CROSSREF], [CSA]
- Risau W. Mechanisms of angiogenesis. Nature 1997; 386: 671–674, [INFOTRIEVE], [CROSSREF], [CSA]
- Ruegg C., Dormond O., Foletti A. Suppression of tumor angiogenesis through the inhibition of integrin function and signaling in endothelial cells: which side to target?. Endothelium 2002; 9: 151–160, [INFOTRIEVE], [CROSSREF], [CSA]
- Sasamura H., Takahashi A., Yuan J., Kitamura H., Masumori N., Miyao N., Itoh N., Tsukamoto T. Antiproliferative and antiangiogenic activities of genistein in human renal cell carcinoma. Urology 2004; 64: 389–393, [INFOTRIEVE], [CROSSREF], [CSA]
- Scatena M., Giachelli C. The alpha(v)beta3 integrin, NF-kappaB, osteoprotegerin endothelial cell survival pathway. Potential role in angiogenesis. Trends in Cardiovascular Medicine 2002; 12: 83–88, [INFOTRIEVE], [CROSSREF], [CSA]
- Siemann D. W., Chaplin D. J., Horsman M. R. Vascular-targeting therapies for treatment of malignancy disease. Cancer 2004; 100: 2491–2499, [INFOTRIEVE], [CROSSREF], [CSA]
- Tokunaga O., Fan J. L., Watanabe T. O. Atherosclerosis-and age-related multinucleated variant endothelial cells in primary culture from human aorta. American Journal of Pathology 1989; 135: 967–976, [INFOTRIEVE], [CSA]
- Vittet D., Buchou T., Schweitzer A., Dejana E., Huber P. Targeted null-mutation in the vascular endothelial-cadherin gene impairs the organization of vascular-like structure in embryoid bodies. Proceedings of the National Academy of Sciences of the United States of America 1997; 94: 6273–6278, [INFOTRIEVE], [CROSSREF], [CSA]
- Weber C., Negrescu E., Erl W., Pietsch A., Frankenberger M., Ziegler-Heitbrock H. W., Siess W., Weber P. C. Inhibitors of protein tyrosine kinase suppress TNF-stimulated induction of endothelial cell adhesion molecules. The Journal of Immunology 1995; 155: 445–451, [CSA]
- Wu J. Q., Sheibani N. Modulation of VE-Cadherin and PECAM-1 mediated cell-cell adhesions by mitogen-activated protein kinases. Journal of Cellular Biochemistry 2003; 90: 121–137, [INFOTRIEVE], [CROSSREF], [CSA]
- Yamada T., Fan J., Shimokama T., Tokunaga O., Watanabe T. Induction of fatty streak-like lesions in vitro using a culture model system simulating arterial intima. American Journal of Pathology 1992; 141: 1435–1444, [INFOTRIEVE], [CSA]
- Yang J. T., Rayburn H., Hynes R. O. Embryonic mesodermal defects in alpha 5 integrin-deficient mice. Development 1993; 119: 1093–1105, [INFOTRIEVE], [CSA]